MedTrace Logo

Quality of Life in Patients With Allergic Rhinitis: Clinical Trial With Bilastine or Loratadine

NCT02513290 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2018-05-07

No results posted yet for this study

Summary

The purpose of this study was to verify whether there were differences in health-related quality of life of patients with allergic rhinitis treated with bilastine 20 mg compared to those treated with loratadine 10 mg.

Conditions

  • Allergic Rhinitis

Interventions

DRUG

Bilastine

DRUG

Loratadine

Sponsors & Collaborators

  • Universidade do Sul de Santa Catarina

    lead OTHER_GOV

Principal Investigators

  • Jane da Silva, PhD · Universidade do Sul de Santa Catarina

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-08-31
Completion
2014-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02513290 on ClinicalTrials.gov